Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
BMC Gastroenterology|December 10, 2013
A nationwide population-based study of the inflammatory bowel diseases between 1998 and 2008 in TaiwanShu-Chen Wei, Meng-Hung Lin, Chien-Chih Tung, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 22, 2023
Hepatitis B reactivation: A possible cause of coronavirus disease 2019 vaccine induced hepatitisHsin-Yun Wu, Tung-Hung Su, Chun-Jen Liu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 21, 2024
Serological responses to COVID-19 vaccination in patients with chronic liver diseasesYu-Shan Huang, Szu-Min Hsieh, Feng-Chiao Tsai, et al.
Journal of Gastroenterology and Hepatology|May 1, 2014
Combining TNFSF15 and ASCA IgA can be used as a predictor for the stenosis/perforating phenotype of Crohn's diseaseChien-Chih Tung, Jau-Min Wong, Wen-Chung Lee, et al.
World Journal of Gastroenterology|January 6, 2016
Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patientsWei-Chen Lin, Jau-Min Wong, Chien-Chih Tung, et al.
BMC Gastroenterology|April 9, 2022
Characteristics of primary signet ring cell carcinoma of colon and rectum: a case control studyMeng-Tzu Weng, Ko-Han Chao, Chien-Chih Tung, et al.
Inflammatory Bowel Diseases|September 15, 2017
SHANK3 Regulates Intestinal Barrier Function Through Modulating ZO-1 Expression Through the PKCε-dependent PathwayShu-Chen Wei, Hsin-Fang Yang-Yen, Po-Nien Tsao, et al.
Plos One|June 20, 2014
SLCO3A1, A novel crohn's disease-associated gene, regulates nf-κB activity and associates with intestinal perforationShu-Chen Wei, Yan-Yin Tan, Meng-Tzu Weng, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 3, 2014
High-dose dual therapy is superior to standard first-line or rescue therapy for Helicobacter pylori infectionJyh-Chin Yang, Chun-Jung Lin, Hong-Long Wang, et al.
Inflammatory Bowel Diseases|January 10, 2023
Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) StudyWei-Chen Lin, Wei-Chen Tai, Chung-Hsin Chang, et al.
Pageof 3